Mangrove Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-390,667
Closed -$5.91M 218
2023
Q1
$5.91M Hold
390,667
0.39% 71
2022
Q4
$5.42M Hold
390,667
0.31% 83
2022
Q3
$5.32M Hold
390,667
0.31% 87
2022
Q2
$5.72M Buy
+390,667
New +$6.03M 0.28% 89

Other funds holding BCAT

Mangrove Partners's BCAT Position: Q2 2023 in Review

Mangrove Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2023, closing a stake of 390,667 shares — an estimated $5.91M sold.

Mangrove Partners first reported a position in BCAT in Q2 2022 and held it in 4 quarters. The position peaked at $5.91M in Q1 2023. 72 funds tracked by Wall St. Rank hold BCAT as of Q2 2023.

  • Mangrove Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2023 after selling out during the quarter.
  • Mangrove Partners sold 390,667 BlackRock Capital Allocation Term Trust shares in Q2 2023, an estimated $5.91M.
  • Mangrove Partners first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and held it in 4 quarters.
  • Mangrove Partners's BlackRock Capital Allocation Term Trust position peaked at $5.91M in Q1 2023.
  • 72 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2023.

Based on Mangrove Partners's 13F filing for Q2 2023, filed 14 Aug 2023.